FDA grants emergency use authorization to J&J COVID-19 vaccine | Inquirer News

FDA grants emergency use authorization to J&J COVID-19 vaccine

By: - Reporter / @KAguilarINQ
/ 11:51 PM April 19, 2021

MANILA, Philippines — Johnson & Johnson has secured an emergency use authorization (EUA) for its Janssen COVID-19 vaccine from the Food and Drug Administration (FDA), Secretary Carlito Galvez Jr., the country’s vaccine manager, said Monday.


“Regarding Johnson & Johnson, we thank the FDA because its EUA has been released. Now, we have five vaccines with an EUA,” Galvez said in Filipino during a pre-recorded meeting of President Rodrigo Duterte with his Cabinet.

“The only ones left [with an EUA] are Moderna at Novovax,” he added.


The four other vaccines that have secured an EUA are those developed by Sinovac BioTech, AstraZeneca, Pfizer-BioNTech, and Russia’s Gamaleya Institute.

The Philippines has already reserved six million doses of J&J’s single-shot vaccine, Philippine Ambassador to the United States Jose Romualdez previously said.

J&J’s vaccine is said to be 85.4 percent effective in preventing the severe respiratory disease.


What you need to know about the Johnson & Johnson vaccine


For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, coronavirus Philippines, COVID-19 Vaccines, Janssen Pharmaceuticals, Johnson & Johnson
For feedback, complaints, or inquiries, contact us.

© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.